Moderately to Severely Active Ulcerative Colitis (UC)
Immunology
3 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Approved(2)
Phase 2(1)
| Drug | Company |
|---|---|
| tamuzimod | Ventyx Biosciences, Inc. (VTYX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Moderately to Severely Active Ulcerative Colitis (UC)?
BioSniper tracks 3 drugs in development for Moderately to Severely Active Ulcerative Colitis (UC) across 2 companies.
How many clinical trials target Moderately to Severely Active Ulcerative Colitis (UC)?
There are 1 clinical trial targeting Moderately to Severely Active Ulcerative Colitis (UC) tracked by BioSniper.
Deep-dive into Moderately to Severely Active Ulcerative Colitis (UC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis